Biohaven Ltd.
BHVN
$-0.15
Change (1 day)
$55.70
Year High
$13.87
Year Low
Categories
Biohaven Ltd. is a clinical-stage biopharmaceutical company. The Company focuses on development of therapies for neurological and immunoscience diseases that can change current treatment paradigms.
P/S ratio for Biohaven Ltd. (BHVN)
P/S ratio as of 2024: 0.00
According to Biohaven Ltd.'s latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.00. At the end of 2023 the company had a P/S ratio of 0.00.
P/S ratio history for Biohaven Ltd. from 2017 to 2024
P/S ratio at the end of each year
| Year | P/S ratio |
|---|---|
| 2024 | 0.00 |
| 2023 | 0.00 |
| 2022 | 0.00 |
| 2021 | 0.57 |
| 2020 | 0.00 |
| 2019 | 0.00 |
| 2018 | 0.00 |
| 2017 | 0.00 |